Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 200 Results

Title
Intervention Indication Therapeutic Area Year Actions
Gilteritinib maintenance therapy for FLT3-ITD mutated acute myeloid leukaemia Gilteritinib (ASP2215; Xospata; gilteritinib fumarate) Acute myeloid leukaemia (AML) Haematological Cancer and Lymphomas 2022 View  |  Download
Giredestrant with palbociclib for previously untreated advanced or metastatic breast cancer Giredestrant , Givosiran (ALN-AS1) , Palbociclib Breast cancer Breast Cancer 2022 View  |  Download
Glatiramer Acetate Depot for treating relapsing forms of multiple sclerosis in adults aged 18 to 55 years Glatiramer Acetate Depot (Copaxone) Multiple sclerosis (MS) Nephrology 2022 View  |  Download
Glofitamab with gemcitabine, oxaliplatin and rituximab for treating relapsed or refractory diffuse large B-cell lymphoma Gemcitabine (Gemzar; gemcitabine hydrochloride) , Glofitamab (RG-6026) , Oxaliplatin , Rituximab (MabThera; Rituxan; RG 105) Diffuse large B-cell lymphoma (DLBCL) Haematological Cancer and Lymphomas 2022 View  |  Download
Glucarpidase for methotrexate toxicity Glucarpidase (Voraxaze) Methotrexate toxicity during cancer therapy Oncology , Toxicology 2022 View  |  Download
Guselkumab for treating moderately to severely active Crohn’s disease Guselkumab (Tremfya; CNTO-1959) Crohn's disease Gastroenterology , Immunology 2022 View  |  Download
Guselkumab for treating ulcerative colitis Guselkumab (Tremfya; CNTO-1959) Ulcerative colitis Gastroenterology 2022 View  |  Download
High dose aflibercept for treating neovascular age-related macular degeneration (nAMD) Aflibercept Age-related macular degeneration (AMD) Ophthalmology 2022 View  |  Download
High-dose aflibercept for diabetic macular oedema Aflibercept Diabetic macular oedema Endocrine Nutritional and Metabolic Disorders , Ophthalmology 2022 View  |  Download
Idecabtagene vicleucel for treating relapsed or
refractory multiple myeloma after 2 therapies
Idecabtagene vicleucel (Ide-cel; bb2121) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2022 View  |  Download
1 2 7 8 9 10 11 19 20
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications